When was Lindy Biosciences founded?

Lindy Biosciences was founded in 2016 and raised its 1st funding round 2 years after it was founded.

Where is Lindy Biosciences located?

Lindy Biosciences is headquartered in Durham, United States.

Who is the current CEO of Lindy Biosciences?

Karen LeVert of Lindy Biosciences.

How many employees does Lindy Biosciences have?

As of Aug 31, 2026, the latest employee count at Lindy Biosciences is 24.

Is Lindy Biosciences a funded company?

Lindy Biosciences is a funded company, having raised a total of $7.26M across 5 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Mar 06, 2018.

When was the latest funding round of Lindy Biosciences?

Lindy Biosciences' latest funding was a $***** Series B round on Mar 12, 2024, with participation from 0 investor. Its primary sector is Biopharma Outsourcing. In United States, the Biopharma Outsourcing sector has seen $749M in funding in 2026 to date.

Where does Lindy Biosciences rank among its competitors?

Lindy Biosciences ranks 1st amongst 7 active competitors, of which 2 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Lindy Biosciences, which secured $1.71M in Mar, 2024.

Who are the top competitors of Lindy Biosciences?

Lindy Biosciences' top competitors include Magle Group, Accubits Invent and SNH Innovation. Among them, Lindy Biosciences secured the most recent funding round in March, 2024.

Lindy Biosciences - 2026 Company Profile, Team, Funding & Competitors

Lindy Biosciences is a series B company based in Durham (United States), founded in 2016 by Karen LeVert. It operates as a Developer of biotherapeutic drug delivery technology for home medication administration. Lindy Biosciences has raised $7.26M in funding from IAG Capital Partners. The company has 7 active competitors, including 2 that are funded. Its top competitors include companies like Magle Group, Accubits Invent and SNH Innovation.

Company Details

Developer of biotherapeutic drug delivery technology for home medication administration. This company provides a proprietary microglassification platform to formulate antibody therapeutics for self-administration. The technology aims to transition patients away from intravenous infusions conducted in acute care settings toward more convenient home-based treatment options. The business maintains collaborative partnerships with industry entities to support the development of biotherapeutic products.

Website: www.lindybio.com/
Email ID: *****@lindybio.com
Phone Number: +1 **********

Key Metrics

Founded Year

2016

Location

Durham, United States

Stage

Series B

Total Funding

$7.26M in 5 rounds

Latest Funding Round

Series B, Mar 12, 2024, $*****

Investors

IAG Capital Partners & 4 more

Ranked

1^st among 7 active competitors

Employee Count

24 as on Aug 31, 2026

Similar Companies

Magle Group & 5 more

View Lindy Biosciences' full profile

Lindy Biosciences has raised a total funding of $7.26M over 5 rounds. Its first funding round was on Mar 06, 2018. Lindy Biosciences has 5 institutional investors.

Here is the list of recent funding rounds of Lindy Biosciences:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 12, 2024	9869760	Series B	3521377	5486705	5788714	8016506
Mar 25, 2022	3121997	Series B	7689651	5503729	8362942	Good Growth Capital
2020	9392	Series A	6602	6716	4314	5074

Access funding benchmarks and valuations. Sign up today!

View details of Lindy Biosciences's funding rounds and investors

The founders of Lindy Biosciences is Karen LeVert.

Here are the details of Lindy Biosciences' key team members:

Karen LeVert: Co-Founder & CEO of Lindy Biosciences.

View details of Lindy Biosciences's Founder profiles and Board Members

Lindy Biosciences' employee count trend

Lindy Biosciences has 24 employees as of Aug 26. Here is Lindy Biosciences's employee count trend over the years:

Employee count trend for Lindy Biosciences

Uncover Lindy Biosciences' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Lindy Biosciences include Magle Group, Accubits Invent and SNH Innovation. Here is the list of Top 10 competitors of Lindy Biosciences, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Lindy Biosciences 2016, Durham (United States), Series B	Developer of biotherapeutic drug delivery technology for home medication administration	$7.26M	IAG Capital Partners, Good Growth Capital ... & 3 others	41/100
2nd	Magle Group 2017, Malmo (Sweden), Unfunded	CDMO focused on manufacturing starch microsphere products	-	-	34/100
3rd	Accubits Invent 2020, Thiruvananthapuram (India), Funding Raised	Provider of pharmaceuticals nanoparticles	-	C-CAMP, Kerala Startup Mission	33/100
4th	SNH Innovation 2020, Vadodara (India), Unfunded	Developer of nanoparticulate antibody drug conjugates for cancer immunotherapy	-	-	20/100
5th	IOTA NanoSolutions 2005, Liverpool (United Kingdom), Series B	Limited information available	-	Qib.com	19/100
6th	Aries Science Technology 2018, United States, Unfunded	Biobased and sustainable encapsulation solutions for specialized manufacturing industries	-	-	16/100
7th	Ascension Sciences 2018, Vancouver (Canada), Funding Raised	Biotechnology company focused on developing novel nanoparticle therapeutics for therapeutic applications	-	-	16/100